US Patent Issued to KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION on May 27 for "Cancer cell-targeted drug delivery carrier and composition for promoting photo-thermal treatment effects, both of which contain M1 macrophages as active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,311,024, issued on May 27, was assigned to KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (Seoul, South Korea).

"Cancer cell-targeted drug delivery carrier and composition for promoting photo-thermal treatment effects, both of which contain M1 macrophages as active ingredient" was invented by Seung Kuk Baek (Seoul, South Korea) and Nu Ri Im (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a cancer cell-targeted drug delivery carrier, a composition for promoting photo-thermal treatment effects, and the like, which contain M1 macrophages as an active ingredient. The drug delivery carrier of the present...